Octave Bioscience Inc — Form D
Octave Bioscience Inc of MENLO PARK, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-01-07. The offering totals $32.0M, of which $32.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-01-07
- Form: D
- Accession: 0001702278-21-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $32.0M
- Amount sold: $32.0M
- Investors: 14
- Date of first sale: 2020-10-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-385495
Issuer
- Name: Octave Bioscience Inc
- CIK: 0001702278
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: 1440 O'BRIEN DRIVE, MENLO PARK, CA, 94025
- Phone: 917-838-2865
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Mark Weeks | Executive Officer | MENLO PARK, CA |
| Andrea Jackson | Director | Marlborough, MA |
| George Scangos | Director | SAN FRANCISCO, CA |
| A. Grant Heidrich III | Director | MENLO PARK, CA |
| William Hagstrom | Director | MENLO PARK, CA |
| William Hagstrom | Executive Officer | MENLO PARK, CA |
| Marcel Konrad | Executive Officer | MENLO PARK, CA |
| Thomas Hawes | Director | MENLO PARK, CA |
| Brook Byers | Director | San Francisco, CA |
| Doug Biehn | Director | MENLO PARK, CA |
| Doug Biehn | Executive Officer | MENLO PARK, CA |
| Lucy Coassin | Director | MENLO PARK, CA |
| Michael Pellini | Director | MENLO PARK, CA |
| Melinda Thomas | Executive Officer | MENLO PARK, CA |
Other filings by this issuer (4)
More